BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28089499)

  • 1. The stability of gadolinium-based contrast agents in human serum: A reanalysis of literature data and association with clinical outcomes.
    Prybylski JP; Semelka RC; Jay M
    Magn Reson Imaging; 2017 May; 38():145-151. PubMed ID: 28089499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.
    Frenzel T; Lengsfeld P; Schirmer H; Hütter J; Weinmann HJ
    Invest Radiol; 2008 Dec; 43(12):817-28. PubMed ID: 19002053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
    Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
    Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis.
    Prybylski JP; Jay M
    Adv Chronic Kidney Dis; 2017 May; 24(3):176-182. PubMed ID: 28501081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
    Chehabeddine L; Al Saleh T; Baalbaki M; Saleh E; Khoury SJ; Hannoun S
    Crit Rev Toxicol; 2019 Mar; 49(3):262-279. PubMed ID: 30942117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents.
    Runge VM
    Invest Radiol; 2017 Jun; 52(6):317-323. PubMed ID: 28368880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of equilibrium and kinetic properties in the dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to physiological conditions.
    Baranyai Z; Brücher E; Uggeri F; Maiocchi A; Tóth I; Andrási M; Gáspár A; Zékány L; Aime S
    Chemistry; 2015 Mar; 21(12):4789-99. PubMed ID: 25678406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.
    Fretellier N; Poteau N; Factor C; Mayer JF; Medina C; Port M; Idée JM; Corot C
    Invest Radiol; 2014 Dec; 49(12):766-72. PubMed ID: 24943092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
    Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
    Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of gadolinium-containing contrast-enhancing agents with colorimetric calcium laboratory testing.
    Löwe A; Balzer T; Hirt U
    Invest Radiol; 2005 Aug; 40(8):521-5. PubMed ID: 16024990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H; Lengsfeld P; Steger-Hartmann T; Löwe A; Frenzel T; Hütter J; Sieber MA
    Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
    Laurent S; Elst LV; Muller RN
    Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition.
    Aime S; Caravan P
    J Magn Reson Imaging; 2009 Dec; 30(6):1259-67. PubMed ID: 19938038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method.
    Kang HP; Scott MG; Joe BN; Narra V; Heiken J; Parvin CA
    Clin Chem; 2004 Apr; 50(4):741-6. PubMed ID: 14962999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.